Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - WILLIS TOWERS WATSON PLC

23rd Mar 2021 12:24

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the

ORD

dealings being disclosed relate (Note 2)
Date of dealing

22 March 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,804,555

1.40%

184,156

0.14%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

102,935

0.08%

7,066

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,913,590

1.48%

197,322

0.15%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

1

221.4800 USD

Purchase

5

220.1000 USD

Purchase

50

221.3200 USD

Purchase

60

220.5100 USD

Purchase

70

220.9300 USD

Purchase

100

221.0800 USD

Purchase

100

220.6400 USD

Purchase

102

221.1845 USD

Purchase

200

220.8750 USD

Purchase

253

220.9212 USD

Purchase

290

220.6220 USD

Purchase

294

221.1658 USD

Purchase

300

220.9800 USD

Purchase

335

220.9880 USD

Purchase

400

221.0225 USD

Purchase

500

221.1490 USD

Purchase

600

221.1562 USD

Purchase

700

220.8757 USD

Purchase

700

220.9907 USD

Purchase

734

220.7391 USD

Purchase

757

221.1200 USD

Purchase

900

221.0255 USD

Purchase

1,045

220.8565 USD

Purchase

1,244

221.2708 USD

Purchase

1,464

220.7890 USD

Purchase

3,137

220.8000 USD

Purchase

3,265

220.8172 USD

Purchase

3,786

220.6028 USD

Purchase

4,325

220.7105 USD

Purchase

5,449

220.7370 USD

Purchase

5,556

220.5726 USD

Purchase

6,132

220.0496 USD

Purchase

9,703

220.9688 USD

Purchase

14,056

221.0305 USD

Purchase

20,014

220.7996 USD

Sale

9

221.6800 USD

Sale

11

221.6700 USD

Sale

20

220.9100 USD

Sale

35

220.9288 USD

Sale

41

220.0200 USD

Sale

56

220.7600 USD

Sale

57

221.1200 USD

Sale

60

220.5100 USD

Sale

70

220.9300 USD

Sale

100

220.7850 USD

Sale

100

220.9450 USD

Sale

100

220.0300 USD

Sale

100

220.3200 USD

Sale

128

220.0000 USD

Sale

140

220.6014 USD

Sale

162

220.3729 USD

Sale

165

220.7864 USD

Sale

200

221.0025 USD

Sale

200

220.5750 USD

Sale

293

220.5431 USD

Sale

294

221.1658 USD

Sale

300

221.0600 USD

Sale

314

220.1592 USD

Sale

400

220.9562 USD

Sale

760

220.8725 USD

Sale

946

220.1760 USD

Sale

1,145

220.8760 USD

Sale

1,260

220.3911 USD

Sale

1,685

220.4105 USD

Sale

1,806

220.8003 USD

Sale

2,356

220.8290 USD

Sale

3,031

220.8000 USD

Sale

3,205

220.8653 USD

Sale

5,275

220.7349 USD

Sale

5,484

220.6346 USD

Sale

7,762

220.9789 USD

Sale

7,789

220.2871 USD

Sale

20,000

221.0466 USD

Sale

20,851

220.8076 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?YES
Date of disclosure:

23 Mar 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or

Number of

Exercise

Type

Expiry

 

purchased

relevant securities

price

 

date

 

 

to which the option

 

 

 

 

 

or derivative

 

 

 

 

 

relates

 

 

 

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005678/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,837.91
Change26.87